Searched for
CANSINO BIOLOGICS INC
Afraid of needles? China rolling out oral COVID-19 vaccineThe vaccine, a mist that is sucked in through the mouth, is being offered for free as a booster dose for previously vaccinated people, acco...
China launches a COVID-19 vaccine inhaled through the mouthThe vaccine, a mist that is sucked in through the mouth, is being offered for free as a booster dose for previously vaccinated individuals,...
CanSino's inhaled Covid-19 vax gets emergency use nod in ChinaThe inhaled version of Cansino's adenovirus-vectored Covid-19 vaccine has obtained the green light from the National Medical Products Admin...
Vaccine blood-clot side effect puts focus on immune reactionThe pressure is on for governments that want to hasten immunizing millions of people over the next few months to understand the risk and av...
Pakistan approves emergency use of third Chinese COVID-19 vaccine despite low efficacy rateThe Drug Regulatory Authority of Pakistan (DRAP) on Thursday granted Emergency Use Authorisation (EUA) to CoronaVac, developed by Chinese c...
Pakistan approves emergency use of third Chinese COVID vaccine, despite its low efficacy rateCiting officials, Geo News reported that the Drug Regulatory Authority of Pakistan (DRAP) has granted Emergency Use Authorization (EUA) to ...
CanSinoBIO offered tens of millions of COVID-19 vaccine doses to COVAX: ExecutiveChina has four locally developed COVID-19 vaccines approved for public use and pledged earlier to supply 10 million doses to COVAX without ...
China aims to vaccinate 40% of population by end of July: Senior adviserZhong Nanshan, a coronavirus expert who helped shape China's COVID-19 response, said on Monday the current ratio of vaccine doses administe...
Pakistan approves fourth COVID-19 vaccineChinese company Cansino Biologics Inc's vaccine was approved by the Drug Regulatory Authority of Pakistan (Drap) on Friday.
Pakistan approves Russia's Sputnik-V COVID-19 vaccine for emergency use"Sputnik has received EUA (emergency use authorisation)," the minister, Faisal Sultan, told Reuters in a WhatsApp text message.
Pakistan: China to gift half million doses of Sinopharm vaccine"They have said send your aircraft and airlift this vaccine immediately. So this is a happy bit of news for us, and we will hopefully be su...
China to vaccinate 50 million people for Lunar New Year - SCMPChina has granted emergency-use status to two candidate vaccines from Sinopharm and one from Sinovac Biotech. It has approved a fourth, fro...
Fosun Pharma to buy 100 million doses of BioNTech's COVID-19 vaccine for mainland ChinaFosun said it will be entitled to 60% of annual gross profit from sales of doses that it will make from imported bulk ingredients, and 65% ...
AstraZeneca setback delivers a harsh reality check on vaccine risksIn a world crippled by the pandemic, the setback comes as a reminder that vaccines can fail, or worse, that they can sometimes deliver more...
Covid-19 vaccine front-runner held back by China’s spat with CanadaChinese customs hasn’t approved shipments of CanSino’s vaccine to Canada, the National Research Council of Canada said in a Aug. 26 email. ...
China healthcare, consumer shares fuel strong rallyAt the close, the Shanghai Composite index was up 0.36% at 3,451.09, while the blue-chip CSI300 index slipped 0.05%.
No country for Chinese vaccine: China's big drug maker not able to conduct overseas trialsIf history is any guide, domestic use-only could be a path for China: An Ebola vaccine, also jointly developed by CanSino and the military ...
Wall Street closes higher, Nasdaq sets record as potential vaccines show promiseThe Dow Jones Industrial Average rose 8.92 points, or 0.03%, to 26,680.87, the S&P 500 gained 27.11 points, or 0.84%, to 3,251.84 and the N...
The four front runners of the race for Covid vaccineThe vaccines for the deadly Covid-19 are in various stages of trial. ET takes a look at four vaccine candidates, where the results of the c...
How a Chinese firm jumped to the front of the virus vaccine raceIn May, CanSino became the first globally to publish a full scientific study on its early human trials, an important step because it allows...